Ask AI
ProCE Banner Activity

Enhancing Resistant Hypertension Care: Appropriate Screening and Treatment for Aldosterone-Related Considerations

Clinical Thought

Examine evidence-based and guideline-directed approaches to diagnosing resistant hypertension, such as using appropriate blood pressure measurement techniques, ruling out pseudoresistance, and screening for aldosterone-driven disease. Then enhance your understanding of the latest advancements in managing resistant hypertension with mineralocorticoid receptor antagonists and aldosterone synthase inhibitors.

Released: August 24, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Target Audience

This activity is intended for cardiology physicians, nurse practitioners, and physician associates and other HCPs involved in the care of patients with hard-to-control hypertension. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate the pathophysiologic role of aldosterone excess in driving cardiovascular and kidney morbidity among patients with hard-to-control hypertension to inform clinical assessment and decision-making

Financial Disclosures

Primary Author

Debbie Cohen, MD: consultant/advisor/speaker: AstraZeneca, Kardigan, Medtronic, Novartis, Recor; researcher: Mineralys.